Cadence Pharmaceuticals, Inc. (CADX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	55.08M
Investments in marketable securities	2.33M
Restricted cash	548K
Accounts receivable, net	9.3M
Inventory	8.65M
Prepaid expenses	1.9M
Other current assets	91K
Total current assets	77.89M
Property and equipment, net	2.06M
Intangible assets, net	10.75M
Restricted cash	92K
Other assets	16K
Total assets	90.8M
Accounts payable	7.72M
Accrued liabilities	18.04M
Deferred revenue	0
Current debt, less discount of $429	10.78M
Total current liabilities	36.54M
Long-term debt, less current portion and discount of $506 and $894, respectively	18.54M
Other liabilities	844K
Total liabilities	55.93M
Commitments and contingencies (Note 11)	0
Common stock, $0.0001 par value; 100,000,000 shares authorized, 63,583,065 shares and 63,107,361 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	9K
Additional paid-in capital	506.82M
Accumulated other comprehensive income	0
Accumulated deficit	-471.95M
Total stockholders' equity	34.88M
Total liabilities and stockholders' equity	90.8M

Entities mentioned with CADX

View All Entities